Aims To test the accuracy of four measures of peripheral diabetic neuropathy in a primary care population.
Introduction [2] . The loss of different sensory modalities leads to failure to sense minor trauma, altered plantar pressure and deformity of the foot, leading to ulceration. Diabetic foot ulcers are the main cause of non-traumatic lower limb amputation in developed countries and account for more hospital bed occupancy than any other diabetic complication [3, 4] . The incidence of foot ulceration can be reduced by earlier detection of peripheral neuropathy and subsequent greater attention to foot care [5] . Yet few diabetic patients have regular adequate examinations of their feet [6, 7] .
There are several different methods for detection of peripheral neuropathy, ranging from quantitative methods, such as nerve conduction studies and vibration sense testing, to validated questionnaires. However, each assesses different nerve fibre functions; nerve conduction studies test only 25% of total nerve function [8] . Most methods have been developed and evaluated in specialist clinic settings and are therefore susceptible to spectrum bias. In other words, an instrument tested in a specialist clinic population may only be valid for one end of the spectrum of disease. Although there is no agreed gold standard for detecting peripheral neuropathy, vibration sense has previously been used as such [9] . An accurate measure of neuropathy should be different in those with and those without diabetes [10] , as well as being related to features associated with diabetic neuropathy, such as HbA 1c , age, diabetes duration and the presence of other diabetic complications [11] [12] [13] [14] [15] .
We aimed to assess the validity of four different methods for detecting neuropathy using a large population-based sample of people with Type 2 diabetes and a matched control group, in order to ascertain the most appropriate method of screening for neuropathy in primary care.
Methods
Patients were recruited from the general practice-based diabetes registers of 41 practices in Cambridgeshire, a semirural county in eastern England. Patients were defined as having Type 2 diabetes if the diagnosis occurred after the age of 30 years and if insulin therapy had not been used in the first year after diagnosis. Type 2 diabetic patients (n = 544) aged 45-76 years were randomly selected and for each diabetic patient a non-diabetic control was chosen from the same practice with matching for age and gender. The exclusion criteria for individuals in the control group were HbA 1c values ≥ 6% or a diagnosis of diabetes in the medical records. Patients were invited by letter to attend their local surgery for measurement and structured interviews by trained research nurses.
Anthropometric measurements were undertaken with the participants wearing light clothing. Height was measured in centimetres using a fixed stadiometer. Weight in kilograms and percentage body fat were measured by impedance using Tanita electronic scales (Tanita Corp., Tokyo, Japan). Waist-hip ratio (WHR) was calculated using the waist circumference, measured halfway between the lowest point of the rib cage and the iliac crest, and the hip circumference, measured at the level of the greater trochanter. Systolic and diastolic blood pressure were measured three times on the right arm, 1 min apart, using an automatic sphygmomanometer (Datascope Accutorr 2; Datascope Corp., Montvale, NJ, USA). Whole blood was analysed at one centre (Addenbrooke's Hospital, Cambridge, UK) for serum triglyceride and creatinine using the RA 1000 analyser (Bayer Diagnostics, Basingstoke, UK) and for glycosylated haemoglobin (HbA 1c ) using high-performance liquid chromatography (BioRad Diamat Automated Glycosylated Haemoglobin Analyser, Hemel Hempstead, UK).
Peripheral nerve function was assessed in four different ways. Vibration sense was measured using a handheld biothesiometer (Vibrameter®; Somedic, Hörby, Sweden) that produces repetitive indentation of the skin. This was applied to the dorsomedial aspect of the first metatarsal head of one foot. Vibration perception threshold (VPT) and vibration disappearance threshold (VDT) were measured three times using the method of limits described by Goldberg and Linblom [16] . Each set of measures was assessed for repeatability using correlation coefficient, paired t-tests and Bland-Altman plots. After removal of three discrepant outlying values due to data entry error, the vibration threshold (VT) was calculated as the average of the VPT and VDT. Elevated values of VT imply worse neurological function.
Light touch perception was assessed using a 10-g SemmesWeinstein monofilament (Thio-Feel®; ASTA Medica AG, Frankfurt, Germany). The end of the monofilament was pressed onto the dorsal surface of the great toe with enough pressure to cause the monofilament to buckle. This was done five times for each foot and the participant was unable to see the application of the monofilament during testing. The number of times the monofilament was felt was recorded as a score out of 10 and lower scores corresponded to worse neurological function.
Thermal sensation was measured using the Tip Therm® (Düsseldorf, Germany), an instrument with cold and warm tips. This was applied three times to the dorsum of each foot in a predetermined sequence, unseen by the participant. The participant was asked to identify which tip was being applied. A score for the number of correct answers out of six was obtained, with lower scores corresponding to worse neurological function.
Nurses administered the questionnaire part of the Michigan Neuropathy Screening Instrument (MNSI) to participants in the diabetic group only [17] . The questionnaire was modified for use in the UK and contained 12 questions relating to symptoms of neuropathy, one to general asthenia and one to peripheral vascular disease. It was in two parts, with the participants proceeding to the second part if a positive answer was given to any of the questions in the first part.
Validity was assessed by comparison of values for three measures (VT, light touch score and thermal sense) in the diabetic and control groups and for all four measures in those with and without self-reported retinopathy and nephropathy. In addition, participants were grouped according to age (5-year intervals), duration of diabetes (10-year intervals) and glycosylated haemoglobin values (1% intervals) and all four measures of neuropathy were compared across groups.
Statistical analysis was carried out using STATA Version 6.0 (Stata Corp., College Station, TX, USA). As VT was not normally distributed and the scores for the other instruments were ordered, the Kruskal-Wallis test was used to compare values between different groupings of participants. Variation of VT across ordered score categories was compared using ANOVA, but as Bartlett's test of equal variance was highly significant, a non-parametric analysis had to be done (Kruskal-Wallis) and a χ 2 statistic reported. A non-parametric test for trend across ordered groups, which is an extension of the Wilcoxon rank sum test [18] , was also used. The Mann-Whitney U-test was used to compare the overall scores for light touch and thermal sense between diabetic and control groups. For light touch, thermal sense and questionnaire measures, the sensitivity and specificity for each score to detect neuropathy in the diabetic patients, as defined by the 95th centile of VT values in the control group, were plotted in a receiver operating characteristic (ROC) curve and the area under the curve (AUC) reported. The optimal cut-off score for any measure would be the point on the curve closest to the upper left corner of the graph, i.e. the score with the highest sensitivity and specificity. As the use of the instrument would be for screening for peripheral neuropathy in primary care, sensitivity is likely to be more important than specificity.
The Cambridge Local Research Ethics Committee approved this study.
Results
The characteristics of the diabetic and control populations are shown in Table 1 . The majority (64%) of the patients were male, the median age was 64 years. Almost all were Caucasian, although there were slightly more non-Caucasian participants in the diabetic group than in the control group. The diabetic individuals were, on average, more obese than the control group, with higher values for body mass index (BMI), WHR and percentage body fat. The mean systolic and diastolic blood pressures were higher in the diabetic group than in the control group, as was the serum triglyceride. There was no significant difference in serum creatinine. In the diabetic group, there were no significant differences in clinical, anthropometric and biochemical variables between those with (n = 400) and those without values for VT (n = 144). In the control group, the only significant difference was in diastolic blood pressure, which was higher in those with missing VT values (n = 44) than in those in whom VT was recorded (90 ± 12 (SD) mmHg vs. 85 ± 11 (SD) mmHg, respectively; t = 2.78, P = 0.006).
There were no significant differences between successive measures of VPT and VDT, and correlation coefficients exceeded 0.92. Bland-Altman plots showed that repeated measures of VPT and VDT remained within 2 SD of the difference between the means, although there was increased variation at the upper range of the measurement scale. The differences in neuropathy measurements between the groups and genders are shown in Table 1 . The diabetic patients had higher mean VT values than the control participants, although this difference achieved statistical significance only amongst men. There was a significant difference in light touch score between diabetic and control groups, but no significant difference in thermal score. Women had higher scores than men for light touch, thermal and questionnaire scores, and lower scores than men for VT, the gender differences failing to achieve statistical significance only for light touch. Table 2 shows the statistical association, amongst diabetic patients, of the four measures of neuropathy with increasing age, duration of diabetes and HbA 1c , as well as the presence of retinopathy and nephropathy. Increasing duration of diabetes was associated with significant changes in VT, light touch score, thermal sense and questionnaire score. Increased age was associated with elevated VT values, decreased light touch score and increased thermal score, but there was no significant association with questionnaire score. Only the questionnaire score was significantly associated with HbA 1c . All four measures had significant associations with the presence of retinopathy (16.8% of diabetic patients reported retinopathy), but none was associated with nephropathy (4.1% of diabetic patients reported nephropathy).
Mean values for VT for each category of score for light touch, thermal sense and the neuropathy questionnaire are shown in Table 3 . There was a statistically significant, appropriate variation of VT across the instrument scores: higher VT values were associated with lower monofilament and thermal score and higher questionnaire scores. The trends in variation of VT across the scores were also significant. ROC curves for light touch, thermal sense and neuropathy questionnaire against VT are shown in Fig. 1 . The difference between the AUCs was not statistically significant, although the light touch score had the largest value (0.72; 95% confidence interval 0.63, 0.82).
Discussion
To date, population-based studies have rarely been used to validate measures of neuropathy and this can introduce spectrum bias. Consequently, screening tools for detection of diabetic neuropathy in primary care, where the majority of patients are followed up [7] , may be less effective than expected. In this population-based cross-sectional study of people with diabetes, a control group was also chosen in order to establish a VT-derived threshold for peripheral neuropathy and to allow testing of the instruments in both diabetic and age and gender-matched non-diabetic individuals.
In testing the validity of the instruments, we hypothesized that neuropathy was more likely to be present in people with Mean ± standard deviation reported, except median (interquartile range) for questionnaire score and for triglyceride. N/A, Not applicable (matched data). *P < 0.05 for gender difference; **P < 0.01 for gender difference; ***P < 0.001 for gender difference.
diabetes than controls [10] and that, among diabetic patients, neuropathy would be associated with the duration of diabetes, age, poor glycaemic control, and the presence of other diabetic complications, nephropathy and retinopathy [11] [12] [13] [14] [15] . The measures of neuropathy exhibited validity to varying extents. VT and light touch score were significantly different in diabetic and control groups, but thermal sense measured with a simple device (Tip Therm®) was not. The difference between diabetic and control mean VT values was not as great in women as in men. Within the diabetic and control groups, men tended to have less favourable values (higher VT, lower thermal and light touch scores) for all measures, except the questionnaire. These gender differences may have been due to confounding by other factors, such as height [19] . All four measures were significantly associated with diabetes duration and, with the exception of the questionnaire, with age. All the measures were significantly different in those with from those without retinopathy. However, none of the measures was significantly associated with the presence of nephropathy and only the questionnaire score was associated with HbA 1c . The lack of an association with the presence of nephropathy may be due to imprecision in the assessment of nephropathy, which in this study was by patient self-report. A more sensitive measure of nephropathy, such as microalbuminuria, may have demonstrated an association [15] . HbA 1c is an aggregate measure of glycaemic control over the preceding 2-3 months, therefore an imprecise measure of longer periods of exposure to hyperglycaemia that are associated with the development of neuropathy, and hence changes in the measurement scores. Consequently it may be that some items of the questionnaire score are more responsive to short-term glycaemic changes and this may explain its association with HbA 1c . Values for VT varied across the range of scores for all three instruments as expected, these trends achieving statistical significance. In ROC curve analysis, light touch score had the largest AUC, which may not be surprising given that both VT and light touch score are measures of large fibre nerve function. Vibration threshold appeared to be the most valid measure of peripheral nerve function and was shown to be reliable in a primary care population and setting. This has been previously used as a gold standard, but in primary care may be too expensive and time-consuming for routine use in annual reviews. The other three measures (monofilament, Tip-Therm®, and questionnaire) could more easily be used in general practice, and of these the monofilament light touch score appeared to be the most valid. These measures assess different aspects of neuropathy, light touch testing large fibre neuropathy, thermal sense testing small fibre neuropathy and the questionnaire overall (symptomatic) neuropathy. Thus, tests using a combination of these measures may be more sensitive in identifying early, often subclinical, neuropathy than vibration threshold or light touch score alone. The questionnaire part of the Michigan Neuropathy Screening Instrument has been shown to perform poorly in comparison with the part based on clinical examination, and perhaps should not be used as a stand-alone test without a neurological examination [17] . In addition, relying on symptoms alone has been shown to be a poor measure of neuropathy [20] . However, inclusion of a full neurological examination in all general practice annual reviews is unlikely to be feasible.
Vibration threshold is a continuous measure and by necessity, categorization into a binary outcome will mean the setting of an arbitrary threshold. The 95th and 97th centiles in nondiabetic populations have previously been used as thresholds for neuropathy [21] . Although absolute thresholds (e.g. 25 V) have also been used, this has been for the prediction of foot ulcers, which was not the aim of this study. The level of the chosen threshold may affect the comparisons with other instruments, especially as VT is age-dependent and an overall mean threshold was used [22] . There was a potential source of observer bias, as the interviewers had knowledge of participants' diabetes status prior to testing. This may have led to systematically different measurements between the two groups. However, this comparison was only one of several assessments of validity that led to similar conclusions. Participants with missing values for VT are unlikely to have altered the conclusions, as the only difference was in the control group, where diastolic pressure was higher in those with missing VT values.
The main strength of this paper was that a large populationbased sample was used, whereas previous validation studies have often used clinic-based groups [17] . Vibration sense, tested with the biothesiometer, appeared to be the most valid measure of nerve function, and was also reliable in this population. However, this was a cross-sectional study and the essential property of any such measure in primary care is whether it can predict the onset of ulcers. Both vibration sense and the use of the monofilament have been shown to be useful in this regard, albeit not in population-based samples [22] [23] [24] .
